These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15327439)

  • 21. Pretreatment with pentoxifylline and N-acetylcysteine in liver ischemia reperfusion-induced renal injury.
    Seifi B; Kadkhodaee M; Delavari F; Mikaeili S; Shams S; Ostad SN
    Ren Fail; 2012; 34(5):610-5. PubMed ID: 22364443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of N-acetylcysteine and ozone therapy on oxidative stress and inflammation in acetaminophen-induced nephrotoxicity model.
    Ucar F; Taslipinar MY; Alp BF; Aydin I; Aydin FN; Agilli M; Toygar M; Ozkan E; Macit E; Oztosun M; Cayci T; Ozcan A
    Ren Fail; 2013; 35(5):640-7. PubMed ID: 23560513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of contrast-induced acute kidney injury].
    Guastoni C; De Servi S; Covella P; Turri C; Gidaro B; Bellotti N; Stasi A
    G Ital Nefrol; 2012; 29 Suppl 58():S33-45. PubMed ID: 23229601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
    Shalby AB; Assaf N; Ahmed HH
    Toxicol Mech Methods; 2011 Sep; 21(7):538-46. PubMed ID: 21470069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetylcysteine and acute renal failure: are we doing too little too late?
    Rachoin JS
    Crit Care Med; 2011 Nov; 39(11):2574-5. PubMed ID: 22005235
    [No Abstract]   [Full Text] [Related]  

  • 26. N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.
    Ware K; Qamri Z; Ozcan A; Satoskar AA; Nadasdy G; Rovin BH; Hebert LA; Nadasdy T; Brodsky SV
    Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1421-7. PubMed ID: 23576637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant treatment and outcome of Cortinarius orellanus poisoning: a case series.
    Grebe SO; Langenbeck M; Schaper A; Berndt S; Aresmouk D; Herget-Rosenthal S
    Ren Fail; 2013; 35(10):1436-9. PubMed ID: 23968303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In search of an algorithm to prevent acute kidney injury.
    Dauerman HL
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass.
    Song JW; Shim JK; Soh S; Jang J; Kwak YL
    Nephrology (Carlton); 2015 Feb; 20(2):96-102. PubMed ID: 25384603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond the
    McDonald JS
    AJR Am J Roentgenol; 2023 May; 220(5):761. PubMed ID: 36069487
    [No Abstract]   [Full Text] [Related]  

  • 32. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
    Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
    Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of alpha lipoic acid versus N-acetylcysteine on ifosfamide-induced nephrotoxicity.
    El-Sisi Ael-D; El-Syaad ME; El-Desoky KI; Moussa EA
    Toxicol Ind Health; 2015 Feb; 31(2):97-107. PubMed ID: 23299189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetylcysteine in contrast-induced acute kidney injury: clinical use against principles of evidence-based clinical medicine!
    Sadat U
    Expert Rev Cardiovasc Ther; 2014 Jan; 12(1):1-3. PubMed ID: 24236859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children: translational pharmacokinetics.
    Hanly LN; Chen N; Aleksa K; Cutler M; Bajcetic M; Palassery R; Regueira O; Turner C; Baw B; Malkin B; Freeman D; Rieder MJ; Vasylyeva TL; Koren G
    J Clin Pharmacol; 2012 Jan; 52(1):55-64. PubMed ID: 21263015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotoxicity of contrast media and protective effects of acetylcysteine.
    Briguori C; Quintavalle C; De Micco F; Condorelli G
    Arch Toxicol; 2011 Mar; 85(3):165-73. PubMed ID: 21140133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for the prevention and treatment of acute renal failure.
    Cosentino F
    Cleve Clin J Med; 1995; 62(4):248-53. PubMed ID: 7641393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental experiences in the prevention of acute renal failure.
    Pintér J; Balogh F; Karátson A
    Urol Int; 1966; 21(4):375-80. PubMed ID: 5959071
    [No Abstract]   [Full Text] [Related]  

  • 39. Preconditioning renoprotective effect of isoflurane in a rat model of virtual renal transplant.
    Su MW; Chang SS; Chen CH; Huang CC; Chang SW; Tsai YC; Lam CF
    J Surg Res; 2014 Jun; 189(1):135-42. PubMed ID: 24674838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
    Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
    Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.